Form 8-K · Current Report · Filed 2025-11-21
Pfizer Inc. Completes Public Offering of Various Notes
On November 21, 2025, Pfizer Inc. completed a public offering of various notes totaling $5.75 billion in aggregate principal amount. The notes include Floating Rate Notes due 2027, 3.875% Notes due 2027, 4.200% Notes due 2030, 4.500% Notes due 2032, 4.875% Notes due 2035, 5.600% Notes due 2055, and 5.700% Notes due 2065. The offering was made pursuant to a shelf registration statement and an indenture. The proceeds from the offering will be used for general corporate purposes.
- Filer
- Pfizer Inc. PFE · NYSE
- Filed
- Accession
- 0001193125-25-291406
- CIK
- 0000078003
- Signal
- Medium impactHealthcare
- Source
- Official filing on sec.gov ↗
Items reported
Other Events
Financial Statements and Exhibits
Market reaction
Close before filing
$24.40
Next session
+3.4%
Since filing
+2.5%
Latest close
$25.01
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from PFE reporting the same item, with the next session's move:
About Pfizer Inc.
Pfizer Inc. is a multinational pharmaceutical and biotechnology corporation, recognized for its role in the research, development, and manufacturing of healthcare products. Operating in the health sector, Pfizer focuses on creating innovative medicines and vaccines that significantly improve patients' lives. It is renowned for its contributions to pivotal health areas, such as oncology, immunology, cardiovascular health, and rare diseases. Pfizer maintains a robust pipeline of products at various stages of clinical development, enhancing its market position and impact. The company is instrumental in the global pharmaceutical landscape, contributing to public health with breakthroughs like vaccines and therapies that tackle some of the world's most challenging diseases. Headquartered in New York City, Pfizer plays a critical role in addressing urgent medical needs worldwide and is involved in extensive collaborations with scientific communities and healthcare systems. As a key player in the pharmaceutical industry, Pfizer’s developments and strategic initiatives can influence market trends and health policies, underscoring its importance in the global effort to combat health issues.
Never miss another PFE filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.